Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meifeng Tu

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
BMC Medicine|March 8, 2024
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trialYanfei Liu, Lingyan Ping, Yuqin Song, et al.
Annals of Hematology|September 7, 2016
Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndromeJing Jia, Yuqin Song, Ningjing Lin, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 2, 2013
Prognostic value of interim (18)F-FDG PET/CT in diffuse large B-cell lymphomaZhitao Ying, Xuejuan Wang, Yuqin Song, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Prognostic value of 18F-FDG PET-CT in Hodgkin lymphoma]Zhitao Ying, Xuejuan Wang, Yuqin Song, et al.
Cancer Cell International|January 21, 2014
Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphomaZhiying Fu, Jun Zhu, Wen Zheng, et al.
Cryobiology|July 30, 2020
The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patientsTong Su, Zhitao Ying, Xin-An Lu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Prognostic value of interim and post-therapy 18F-FDG PET-CT in patients with T-cell lymphomas]Xiaopei Wang, Huiying Huang, Zhitao Ying, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|April 19, 2019
Prognostic value of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantationZhitao Ying, Lan Mi, Nina Zhou, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2014
[Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma]Weiwei Song, Yan Xie, Lijuan Deng, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Prognostic value of pre- and post-transplantation <sup>18</sup>F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantationZhitao Ying, Lan Mi, Xuejuan Wang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
BMC Medicine|March 8, 2024
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trialYanfei Liu, Lingyan Ping, Yuqin Song, et al.
Annals of Hematology|September 7, 2016
Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndromeJing Jia, Yuqin Song, Ningjing Lin, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 2, 2013
Prognostic value of interim (18)F-FDG PET/CT in diffuse large B-cell lymphomaZhitao Ying, Xuejuan Wang, Yuqin Song, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Prognostic value of 18F-FDG PET-CT in Hodgkin lymphoma]Zhitao Ying, Xuejuan Wang, Yuqin Song, et al.
Cancer Cell International|January 21, 2014
Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphomaZhiying Fu, Jun Zhu, Wen Zheng, et al.
Cryobiology|July 30, 2020
The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patientsTong Su, Zhitao Ying, Xin-An Lu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Prognostic value of interim and post-therapy 18F-FDG PET-CT in patients with T-cell lymphomas]Xiaopei Wang, Huiying Huang, Zhitao Ying, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|April 19, 2019
Prognostic value of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantationZhitao Ying, Lan Mi, Nina Zhou, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2014
[Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma]Weiwei Song, Yan Xie, Lijuan Deng, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Prognostic value of pre- and post-transplantation <sup>18</sup>F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantationZhitao Ying, Lan Mi, Xuejuan Wang, et al.
Pageof 4